Approved Study Database

Ref. No. Scientific Title Principal investigator
2024.231 Predictive performance of Cerebrospinal Fluid Cell Ratio and Index on Extra-ventricular Drain related Ventriculitis Dr. HO Samantha
2019.085 Biomarkers for poor responders to neoadjuvant chemoradiotherapy for locally advanced rectal cancer Dr. HO Sandy Sze Ki
何詩琪
2013.130 The effectiveness of extracorporeal shockwave therapy De Quervain ms Ho Shuk Ling
2008.033 The Prevalence and Risk Factors of Low Back Pain in Golfers in Hong Kong Mr. Ho Sik Hon
2011.037 The effect of kinesio taping applied on vastus medialis in the enhancement of shuttle run, hurdle run and figure-of-eight agility in normal males. Miss HO SING LONG
2017.658 Attainment of therapeutic vancomycin level in neonates with current dosage recommendation: A retrospective cohort Dr. HO Stephanie
何嘉倫
2018.481 Effect of a multimodal infection control programme on the reduction of bacterial contamination on nasogastric tube feeding for elderly persons in residential care homes Ms. HO Suk Ki
何淑琪
2015.383 The effectiveness of educational intervention on glaucoma patients for improving their topical medication adherence and outcomes: a randomized controlled trial Ms. HO Suk Kwan
何淑坤
2008.259 Parents' Experience of Caring for a Child with Attention Deficit Hyperactivity Disorder: An Exploratory Study Ms Ho Sze Wan Carol
2019.496 A community survey: Exploring the understanding and perception of cannabis among students from faculty of medicine Ms. HO Sze Wing
何思穎
2012.460 Will better knowledge on the understanding of behavior and psychological symptoms of dementia (BPSD) contribute positive care-giving attitude(s) towards dementia inmates? APN(P) HO Tai Tei Isabella
2023.073 Effectiveness evaluation of paper-based cognitive training in reducing cognitive decline for outpatients with early stage of dementia Mr. HO Tak Wai
2020.598 A retrospective cohort study to determine predicting factors for progression of Non-tuberculosis mycobacterium pulmonary disease Dr HO Tracy Hang Yee
何杏儀
2009.464 A Randomized, Double-Blind, Placebo Controlled Study to evaluate the health benefits of Cordyceps mycelium capsules based on the theory of Traditional Chinese Medicine Prof. Ho Walter K.K.
2008.567 Study of neonatal natural killer cell activation through cytokine, bacterial protein and accessory cell stimulations, and comparison with NK cell characteristics from neonates with bacterial infection Dr Ho Wen Ying
2010.096 Study of human primary neonatal natural killer cells in response to challenge with lipoteichoic acid, a major constituent of gram-positive bacteria Dr Ho Wen Ying
2011.461 Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after docetaxel-based regimen Dr. HO Wing Ming
2008.264 An International Multi-Centre Open Label 2-Arm Phase III Trial of Adjuvant Bevacizumab in Triple Negative Breast Cancer Dr. HO Wing Ming
2009.386 A randomized phase III, double-blind, placebo-controlled multicenter trial of Everolimus in combination with Trastuzumab and Paclitaxel, as first line therapy in women with HER2 positive locally advanced or metastatic breast cancer Dr. HO Wing Ming
2007.471 A Randomized Phase 2 Trial of Double-Blind, Placebo Controlled AMG 706 in Combination with Paclitaxel, or Open-Label Bevacizumab in Combination with Paclitaxel, as First Line Therapy in Women with HER2 Negative Locally Recurrent or Metastatic Breast Cancer Dr. HO Wing Ming
2009.412 An open-label, multicenter phase II study to compare the efficacy and safety of RAD001 as first-line followed by second-line sunitinib versus sunitinib as first-line followed by second-line RAD001 in the treatment of patients with metastatic renal cell carcinoma Dr. Ho Wing Ming
2011.177 A Phase II, single-arm study of orally administered BEZ235 as second-line therapy in patients with advanced or metastatic endometrial carcinoma Dr HO Wing Ming
2011.049 A Phase 3, Randomized, Double-Blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Dr. HO Wing Ming
2011.048 An Open Label Study of Abiraterone Acetate in Subjects with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy Dr Ho Wing Ming
2008.092 A Phase II Safety and Efficacy Study with the VEGF Receptor Tyrosine Kinase Inhibitor GW786034 in Patients with Metastatic Urothelial Cancer Dr HO Wing Ming
2011.523 A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers Dr. Ho Wing Ming
2021.496 A Phase III, Open Label, Randomised, 3-Arm, Multi-Centre Study of Savolitinib plus Durvalumab versus Sunitinib and Durvalumab Monotherapy in Participants with MET Driven, Unresectable and Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC) (SAMETA) Dr. HO Wing Ming
何永明
2020.259 A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E) Dr. HO Wing Ming
何永明
2015.389 A Phase Ib/II, Multicentre, Open Label, Randomised Study of BI 836845 in Combination with Enzalutamide, versus Enzalutamide alone, in Metastatic Castration-Resistant Prostate Cancer (CRPC) Following Disease Progression on Docetaxel-Based Chemotherapy and Abiraterone Dr. HO Wing Ming
何永明醫生
2016.343 A Randomized, Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination with and/or Following Chemotherapy in Patients with Previously Untreated Epithelial Ovarian Cancer Dr. HO Wing Ming
何永明醫生
2016.032 Learning Ultrasound in Critical Care (LUCC) Dr. HO Wing Sze
何穎詩
2012.133 A Randomized, Open Label, Multi-National Study of Cabazitaxel At 25 mg/m_ Every 3 Weeks in Combination With Prednisone Compared To Mitoxantrone in Combination With Prednisone in Asian Patients with Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen Dr HO Wing-Ming
2022.114 Retrospective record review on timing of post adult cardiac surgery and Coronavirus disease 2019 vaccination Dr. HO Yan Kit
何殷傑
2021.573 Initial Asian experience of the branched E-vita Open NEO in complex aortic pathologies Dr. HO Yan Kit
2012.551 Predicting Vancomycin Trough Concentrations for Increased Trough Targets in Chinese Population: Comparison of Five Approaches Miss Ho Yan Yan Wendy
2015.543 Equipment Preference of Hong Kong Ambulance in Mountain Rescue Mr. HO Yiu Nam
何燿南
2008.002 Functional Significance of Apolipoprotein Gene Polymorphisms Prof. HO YUAN-YUAN
2008.270 An Exploratory Study of the Stresses and Needs of Chinese Parents During the Hospitalization of Their Preterm Infants Miss Ho Yuen Wah
2019.682 The Prevalence of Bone Density Monitoring and Predictive Factors for Aromatase Inhibitor-related Bone Fractures in Postmenopausal Women with Breast Cancer Mr. HO Yuk Nam
何煜南
2012.039 Effect of antipsychotics on risk of pneumonia and all-cause mortality in elderly patients with dementia: a 1-year retrospective study Ms Ho_x000D_So Wing Lam_x000D_In Yung
2001.489 A Randomized, Double-Blind, Placebo-Controlled, Parallel Study of The Therapeutic Effect And Safety Of A Traditional Chinese Medicine (TCM) For Atopic Dermatitis In Children Prof. HON Ellis Kam Lun
2016.269 Microbiota Profile in Allergic Rhinoconjunctivitis Prof. HON Ellis Kam Lun
韓錦倫
2015.075 Efficacy and tolerability of a multi-action emollient for childhood atopic eczema: a randomized controlled trial Prof. HON Ellis Kam Lun
韓錦倫
2016.018 Determining regulatory T and B cell dysregulation in childhood atopic eczema Prof. HON Ellis Kam Lun
韓錦倫
2016.027 Topically applied allogeneic umbilical cord lining membrane-derived mesenchymal stem cells (MSCs) secretome for wound healing in moderate-to-severe childhood atopic eczema: A pilot study Prof. HON Ellis Kam Lun
韓錦倫
2017.399 Effect of pine-tar shower on itch and disease severity in moderate-to-severe childhood eczema Prof. HON Ellis Kam Lun
韓錦倫
2018.086 Intestinal dysbiosis in eczema and airway allergies in twins Prof. HON Ellis Kam Lun
韓錦倫
2014.414 Respiratory pathogens in the PICU Prof. HON Ellis Kam Lun
2017.361 Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-month Open-label Follow-up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa Prof. HON Ellis Kam Lun
韓錦倫醫生
2015.588 Treatment of Atopic Dermatitis Complicated with Staphylococcus aureus –Using Tea Bath: A Pilot Study Prof. HON Ellis Kam Lun
韓錦倫

Page 99 of 254.